Gastrin levels in patients with colorectal cancer.
In view of previous studies showing gastrin's trophic effects on tumor growth, the authors decided to investigate the relationship between fasting serum gastrin levels and the presence of colorectal carcinoma. Fifty-eight patients were studied: 19 controls who were blood bank donors, 19 patients with colorectal neoplasms, Dukes' Stage B or C, and 20 patients with advanced colorectal neoplasms (Dukes' Stage D). Pre-surgical and post-surgical serum gastrin levels were compared in patients with colorectal neoplasms (Dukes' Stage B or C). The mean serum gastrin level was 32.3 pg/ml for the control group, 52.1 pg/ml for the second group and 49.5 pg/ml for the third group. There were no differences between patients before and after surgery. These results do not confirm the hypothesis that gastrin levels are elevated in colorectal cancer patients.